Compare Li Auto Inc (LI) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Li Auto Inc vs Teladoc Health Inc — how do they compare? Li Auto Inc trades at $12.48 (market cap $12.28B), while Teladoc Health Inc trades at $6.62 (market cap $1.24B). The key difference: Li Auto Inc is far larger — about 9.9× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Li Auto Inc nearer its low. Which is the better fit depends on your goals.
| LI | TDOC | |
|---|---|---|
Market Cap | $12.28B | $1.24B |
Sector | Consumer Cyclical | Health |
52-Week High | $26.69 | $9.72 |
52-Week Low | $11.74 | $4.47 |
Enterprise Value | $1.11B | $1.50B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Li Auto (LI) trades at $12.49, down 2.73% on the day, amid a bearish technical signal and mixed earnings performance. The company reported a net income margin of -1.66% for 2025, with revenue declining to $112.31 billion from $144.5 billion in 2024, while launching new SUV models like the Li L6 in July 2026 to boost deliveries. Analyst consensus is a 'Buy' with a $14.80 price target, but negative cash flow and competitive pressures in China's EV market pose challenges.
Outlook remains cautious due to profitability concerns and volatile cash flows, with near-term risks from domestic competition and global expansion hurdles. The stock offers potential upside if execution improves, but investors should monitor delivery trends and margin recovery amid industry headwinds.
Teladoc Health (TDOC) trades at $6.62, down 6.5% on the day, reflecting investor concern after a Q2 2026 revenue miss and lowered full-year guidance. The stock is technically bearish with key support at $6, while fundamentals show revenue of $2.53B in 2025 but persistent net losses, with a negative net income margin of -7.13%. Recent news highlights multiple law firm investigations into the company following its guidance cut.
The outlook remains challenging due to weak BetterHelp performance and ongoing losses, though valuation ratios like P/S of 0.49 and EV/EBITDA of 6.96 suggest potential undervaluation. Risks include competitive pressures and legal scrutiny, but analyst consensus price target of $8.88 implies upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Li Auto Inc
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
